rs28936395
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_017449.5(EPHB2):c.2032G>A(p.Asp678Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00535 in 1,614,172 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D678E) has been classified as Uncertain significance.
Frequency
Consequence
NM_017449.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EPHB2 | NM_017449.5 | c.2032G>A | p.Asp678Asn | missense_variant | 11/16 | ENST00000374630.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EPHB2 | ENST00000374630.8 | c.2032G>A | p.Asp678Asn | missense_variant | 11/16 | 1 | NM_017449.5 | P4 | |
EPHB2 | ENST00000400191.7 | c.2032G>A | p.Asp678Asn | missense_variant | 11/17 | 1 | |||
EPHB2 | ENST00000374632.7 | c.2035G>A | p.Asp679Asn | missense_variant | 11/16 | 1 | A1 | ||
EPHB2 | ENST00000374627.1 | c.2017G>A | p.Asp673Asn | missense_variant | 11/15 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00315 AC: 480AN: 152172Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00347 AC: 872AN: 251398Hom.: 0 AF XY: 0.00343 AC XY: 466AN XY: 135898
GnomAD4 exome AF: 0.00558 AC: 8163AN: 1461882Hom.: 31 Cov.: 31 AF XY: 0.00535 AC XY: 3888AN XY: 727246
GnomAD4 genome ? AF: 0.00315 AC: 480AN: 152290Hom.: 3 Cov.: 32 AF XY: 0.00295 AC XY: 220AN XY: 74460
ClinVar
Submissions by phenotype
Prostate cancer/brain cancer susceptibility Pathogenic:1Benign:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2004 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
EPHB2-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 18, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at